HIV AIDS

>

Latest News

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies / Image credit: ©Ezume Images/AdobeStock
New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies

July 8th 2025

New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.

 Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision / image credit ©Waldenmarus/stock.adobe.com
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision

June 19th 2025

Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV / Image credit: ©Sherry Young/AdobeStock
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV

March 19th 2025

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Real-World Use of Cabotegravir for HIV PrEP

October 25th 2023

IDWeek 2023: New Data Provides Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP / Image credit: ©Chris Bjornberg/AdobeStock
IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP

October 15th 2023

More News

© 2025 MJH Life Sciences

All rights reserved.